|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||869.645 g/mol g·mol−1|
|3D model (JSmol)|
Olcegepant (INN, code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.
A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|